384 related articles for article (PubMed ID: 32359101)
1. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.
Roche JA; Roche R
FASEB J; 2020 Jun; 34(6):7265-7269. PubMed ID: 32359101
[TBL] [Abstract][Full Text] [Related]
2. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
Ghahestani SM; Mahmoudi J; Hajebrahimi S; Sioofy-Khojine AB; Salehi-Pourmehr H; Sadeghi-Ghyassi F; Mostafaei H
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):13-17. PubMed ID: 32534506
[TBL] [Abstract][Full Text] [Related]
4. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Huang Y; Xie C; Chen X; Hong Q; Huang H
Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
[No Abstract] [Full Text] [Related]
5. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
van de Veerdonk FL; Kouijzer IJE; de Nooijer AH; van der Hoeven HG; Maas C; Netea MG; Brüggemann RJM
JAMA Netw Open; 2020 Aug; 3(8):e2017708. PubMed ID: 32789513
[TBL] [Abstract][Full Text] [Related]
6. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
7. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Danser AHJ; Epstein M; Batlle D
Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
9. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
10. Exercise as medicine for COVID-19: An ACE in the hole?
Heffernan KS; Jae SY
Med Hypotheses; 2020 Sep; 142():109835. PubMed ID: 32428811
[No Abstract] [Full Text] [Related]
11. COVID-19 and the Heart.
Akhmerov A; Marbán E
Circ Res; 2020 May; 126(10):1443-1455. PubMed ID: 32252591
[TBL] [Abstract][Full Text] [Related]
12. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Dtsch Med Wochenschr; 2020 May; 145(10):682-686. PubMed ID: 32323279
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
[No Abstract] [Full Text] [Related]
14. Can beta-adrenergic blockers be used in the treatment of COVID-19?
Vasanthakumar N
Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480
[No Abstract] [Full Text] [Related]
15. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Esler M; Esler D
J Hypertens; 2020 May; 38(5):781-782. PubMed ID: 32195824
[No Abstract] [Full Text] [Related]
16. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
de Maat S; de Mast Q; Danser AHJ; van de Veerdonk FL; Maas C
Semin Thromb Hemost; 2020 Oct; 46(7):835-837. PubMed ID: 32526773
[No Abstract] [Full Text] [Related]
17. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
18. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
[TBL] [Abstract][Full Text] [Related]
19. [2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].
Shi HZ; Ma P; Gao FY; Chen GL; Wang YH; Xian XD; Dong ED
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):532-538. PubMed ID: 32166940
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and the cardiovascular system.
Zheng YY; Ma YT; Zhang JY; Xie X
Nat Rev Cardiol; 2020 May; 17(5):259-260. PubMed ID: 32139904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
